Juvenile dermatomyositis
- 1 May 1996
- journal article
- review article
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 37 (2) , 106-108
- https://doi.org/10.1111/j.1440-0960.1996.tb01018.x
Abstract
Juvenile dermatomyositis (JDMS) is a chronic inflammatory condition characterized by muscle weakness and a distinctive rash caused by underlying vasculopathy. Long-term complications include subcutaneous and muscular calcification, contractures and in some cases the gradual development of a second connective tissue disease. Early aggressive treatment with systemic immunosuppressants and other agents such as intravenous immunoglobulin (IVIG) reduces mortality and morbidity.Keywords
This publication has 13 references indexed in Scilit:
- Intravenous immunoglobulin in juvenile dermatomyositis--four year review of nine cases.Archives of Disease in Childhood, 1995
- Analysis of the mi-2 autoantigen of dermatomyositisArthritis & Rheumatism, 1995
- Scalp involvement in dermatomyositis. Often overlooked or misdiagnosedPublished by American Medical Association (AMA) ,1994
- Juvenile dermatomyositis: treatment with intravenous gammaglobulinBritish Journal of Dermatology, 1994
- A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for DermatomyositisNew England Journal of Medicine, 1993
- Dermatomyositis associated with multifocal lipoatrophyPublished by Elsevier ,1990
- Intravenous pulse methylprednisolone treatment of juvenile dermatomyositisArthritis & Rheumatism, 1987
- Prognosis in Juvenile Dermatopolymyositis: A Cooperative Retrospective Study of 70 CasesPediatric Dermatology, 1985
- Juvenile dermatomyositis: A clinical and immunologic studyThe Journal of Pediatrics, 1980
- The epidemiology of polymyositisThe American Journal of Medicine, 1970